Unparalleled.Genomics.Solutions.

The biotech platform for drug discovery, pipeline tracking and market intelligence.

Features

Genomic Analysis

Upload genetic data, detect variants, and get genotype-aware health insights.

Biomarker Tracking

Track health metrics over time from wearables, labs, and manual entry with unit standardization.

Drug Discovery

Manage therapeutic assets across small molecules, biologics, peptides, and oligonucleotides.

Knowledge Graph

Drug-target mechanisms, bioactivities, and therapeutic efficacies linked to evidence sources.

LIMS Integration

Subject management, biospecimen tracking, assay protocols, and quantitative readouts.

Patent Intelligence

Track patents, claims, assignees, licensing agreements, and regulatory approvals.

Development Pipelines

Monitor drug development stages, market organizations, and technology platforms for investors and pharma teams.

Personalized Recommendations

Evidence-backed treatment suggestions based on your genomic profile and biomarker data.

How It Works

Step 1

Choose Your Focus

Select a therapeutic area, company, gene target, or ask a question in plain English.

Step 2

Traverse the Graph

AI navigates 233,000+ biomedical entities: genes → proteins → drugs → trials → patents — all linked by evidence.

Step 3

Get Grounded Answers

Every claim traceable to PubMed papers, ClinicalTrials.gov, DrugBank, and patent databases. Zero hallucination.

Step 4

Make Decisions

Investment thesis validation, drug repurposing opportunities, competitive pipeline analysis, and personalized health insights.

Use Cases

One platform. Three ways to discover biotech intelligence.

Biotech Company

Pipeline Intelligence

Deep dive your competitors' pipeline. Map drug targets, track clinical trials, monitor patent filings across therapeutic areas.

Q

“Which companies target EGFR in NSCLC?”

Osimertinib (AstraZeneca, Phase IV) → Lorlatinib (Pfizer, Phase III) → 12 patents filed in 2024

Investor / VC

Market Intelligence

Ask any question about biotech. Get grounded answers with source citations from PubMed, ClinicalTrials.gov, and patent databases.

Q

“What's the GLP-1 competitive landscape?”

Novo Nordisk (Semaglutide) → Eli Lilly (Tirzepatide) → 50+ active trials → $50B+ projected market

Researcher / Doctor

Scientific Discovery

Explore genetic correlations, drug repurposing opportunities, and biological pathway interactions backed by evidence.

Q

“What variants are associated with Alzheimer's risk?”

APOE ε4 (rs429358, 3.7x risk) → APP A673T (protective) → mTOR / Autophagy pathway connections

AI-Powered

Biomedical Intelligence

Not a chatbot. A deterministic query engine over a curated biomedical knowledge graph.

Grounded Answers

Every answer traceable to graph nodes. If it's not in the database with a clear source, the AI cannot invent it. Zero hallucination on data.

7 Query Tools

Company portfolios, drug discovery paths, competitive landscapes, entity networks, pathway exploration, literature search, and variant analysis.

Source Attribution

Every claim linked to PubMed papers, ClinicalTrials.gov entries, or patent filings with confidence scores. Auditable by design.

Example Query

“What drugs does Novo Nordisk have for diabetes and what genes do they target?”

Novo Nordisk has Semaglutide (DB13928) and Liraglutide (DB06655) for Type 2 Diabetes. Both target the GLP-1 receptor (GLP1R) on chromosome 6, which participates in the Insulin Signaling pathway (KEGG hsa04910, Tier S). Semaglutide is in Phase III clinical trials (NCT03548935).

PubMed: 31174883ClinicalTrials.gov: NCT03548935DrugBank: DB13928
233,000+Biomedical Entities
18Companies
135Genes
55Pathways
231,000+Ontology Terms

MCP Integration

Query the biomedical knowledge graph directly from your AI tools. Install the Nexotype MCP server and start asking questions.

Coming Soon

Claude Desktop

Anthropic's desktop app for macOS & Windows

VS Code / Cursor

IDE extensions with MCP support

Claude Code / CLI

Terminal-based AI coding assistants

Get started in 3 steps

1

Install

pip install nexotype-mcp

Or with uv: uv tool install nexotype-mcp

2

Login

nexotype-cli login

Opens your browser automatically. Sign in on the web, then return to your terminal.

3

Configure your AI client

Edit: ~/Library/Application Support/Claude/claude_desktop_config.json

{
  "mcpServers": {
    "nexotype": {
      "command": "nexotype-mcp"
    }
  }
}

Restart the application after saving.

Start a conversation

Open your AI tool and try:

“What drugs target EGFR and are in Phase III?”
“Show me Novo Nordisk's pipeline for metabolic diseases”
“Which variants are associated with Alzheimer's risk?”
“Compare GLP-1 receptor agonists across companies”

Pricing

From personal genomics to enterprise intelligence. Pay for the access you need.

Free

$0/mo

Explore the platform structure and interface.

  • Platform UI access
  • Genetic profile analysis
  • Biomarker tracking
  • Therapeutic asset database
  • Knowledge graph
  • LIMS & engineering
  • Commercial intelligence
Get Started

Personal

$20/mo

For biohackers and health-optimizers tracking their own biology.

  • Upload genetic data (23andMe, WGS)
  • Variant detection & genomic associations
  • Biomarker tracking from wearables & labs
  • Pathway health scores (mTOR, AMPK)
  • Treatment logging & recommendations
  • Drug interactions & safety checks
  • Commercial intelligence
Get Started

Pro

$120/mo

For biotech teams managing drug discovery and research operations.

  • Everything in Personal
  • Full omics registry (genes, proteins, transcripts)
  • Therapeutic asset management (4 modalities)
  • LIMS (subjects, biospecimens, assays)
  • Engineering (candidates, mutations, constructs)
  • Knowledge graph curation & evidence linking
  • Commercial intelligence
Get Started

Enterprise

$360/mo

Full platform access with commercial intelligence and patent analytics.

  • Everything in Pro
  • Patent tracking, claims & assignees
  • Licensing agreements & asset ownership
  • Development pipeline monitoring
  • Regulatory approvals across jurisdictions
  • Market organization intelligence
  • Technology platform analysis
Get Started

Contact

Interested in sharing your ideas with us?

Address
V7 Studio, D. I. Mendeleev 5, Bucharest
Email
robert.radoslav@pm.me